Progression-free and overall survival of patients with SCLC and ECOG performance status 0-1 – Data from the Clinical Research platform Into molecular testing, treatment and outcome of (non-) Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315) 25. Oktober 2024 Waller, C.F.; Fischer, R.; Reck, M.; Gauler, T.; Christopoulos, P., Bruch, H.-R. Grah, C.; Ludwig, P.; Hipper, A.; Medinger, T.; Tech, S.; Binninger, A.; Jänicke, M.; Elender, C.; Christoph, D.C.; Griesinger, F.; Thomas, M.; Eberhardt, W.E.E.; Sebastian, M., 2024, Annual Meeting DGHO, Poster-Nr. P448 Download Tucatinib in patients with locally advanced or metastatic HER2-positive breast cancer who received at least two prior anti-HER2 treatment regimens: Study design of the non-interventional study TRACE in Germany and Austria Arnd Nusch A, Angerer M, Kreiss-Sender J, Radosa J, Uleer C, Wrobel D, Balic M, Egle D, Harbeck N, Müller V, Schumacher-Wulf E, de Buhr… Weiterlesen IDHIRA: A prospective, multicenter, non-interventional study of ivosidenib in patients with IDH1 R132-mutated cholangiocarcinoma Michl M, Hagemeyer N, Grebhardt S, Looss, M, Potthoff K, 2024, AbstractID: AS-DGHO-2024-00336 Posternumber: P1098 Download… Weiterlesen